Patents do not incentivize pediatric cancer drug development because the markets are too small
Impact
2012
Creating Hope Act
Pediatric Priority Review Voucher (PRV) becomes US law
2017
RACE for Children Act becomes US law
2024
Give Kids a Chance Act will become law
Our Ask
2024
Give Kids a Chance Act &
Creating Hope Reauthorization Act PRV reauthorization
Policies
Programs
Get Involved
Our Voices
Evie’s sister, Sadie Murata
Caroline Belcher
Brooke Hester
Our News
Ella Bresee in pink
Wake Up To Politics: September 27, 2024 - Two People Who Inspire Me
Federal Register: September 19, 2024 — FDA Sets New Priority Review User Fee Rate for FY 2025: $2,482,446
STAT News: September 12, 2024 — A rare disease program, portrayed as both lifeline and pharma handout, is set to expire
September 21, 2024 — Climb the Hill Day
Nature Medicine, April 2022 — How to Correct the Market for Children’s Cancer Drugs, by Nancy Goodman
Awards
